Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drucker

Showing results (51-60 of 549) with videos related to

Pageof 55
Sort By:
Cell Metabolism|April 5, 2018
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Daniel J Drucker
Endocrinology|February 13, 2001
Minireview: the glucagon-like peptidesD J Drucker
Pancreas|July 1, 1990
Glucagon and the glucagon-like peptidesD J Drucker
Diabetes|August 24, 2018
The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular ComplicationsDaniel J Drucker
Gastroenterology|February 8, 2002
Biological actions and therapeutic potential of the glucagon-like peptidesDaniel J Drucker
Cell Metabolism|March 7, 2006
The biology of incretin hormonesDaniel J Drucker
Cell Metabolism|June 28, 2016
The Cardiovascular Biology of Glucagon-like Peptide-1Daniel J Drucker
La Revue Du Praticien|June 21, 1991
[Epidemiology of collective infections and toxic-infections of food or water origin. Modalities of survey in front of outbreak]J Drucker, A Decaux
Seminars in Neurology|September 1, 1993
Post-polio syndrome: an updateB Jubelt, J Drucker
Sante (Montrouge, France)|May 1, 1994
[Epidemiological surveillance of measles in France]I Rebière, J Drucker
Pageof 55

Showing results (51-60 of 549) with videos related to

Sort By:
Pageof 55
Cell Metabolism|April 5, 2018
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Daniel J Drucker
Endocrinology|February 13, 2001
Minireview: the glucagon-like peptidesD J Drucker
Pancreas|July 1, 1990
Glucagon and the glucagon-like peptidesD J Drucker
Diabetes|August 24, 2018
The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular ComplicationsDaniel J Drucker
Gastroenterology|February 8, 2002
Biological actions and therapeutic potential of the glucagon-like peptidesDaniel J Drucker
Cell Metabolism|March 7, 2006
The biology of incretin hormonesDaniel J Drucker
Cell Metabolism|June 28, 2016
The Cardiovascular Biology of Glucagon-like Peptide-1Daniel J Drucker
La Revue Du Praticien|June 21, 1991
[Epidemiology of collective infections and toxic-infections of food or water origin. Modalities of survey in front of outbreak]J Drucker, A Decaux
Seminars in Neurology|September 1, 1993
Post-polio syndrome: an updateB Jubelt, J Drucker
Sante (Montrouge, France)|May 1, 1994
[Epidemiological surveillance of measles in France]I Rebière, J Drucker
Pageof 55